Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seroprevalence of endemic and emergent coronaviruses among SARS-COV-2 patients and healthcare workers in Abidjan, Côte d'Ivoire.

BMC infectious diseases·2026
Same author

Revealing trends in measles immunity during periods of varying measles circulation in Madagascar.

American journal of epidemiology·2025
Same author

Strengthening serological studies: the need for greater geographical diversity, biobanking, and data-accessibility.

Trends in microbiology·2025
Same author

Genetic and environmental interactions contribute to immune variation in rewilded mice.

Nature immunology·2024
Same author

Spatiotemporal-social association predicts immunological similarity in rewilded mice.

Science advances·2023
Same author

serosim: An R package for simulating serological data arising from vaccination, epidemiological and antibody kinetics processes.

PLoS computational biology·2023

Related Experiment Videos

Erectile dysfunction and cardiovascular disease.

Arthur Menezes1, Surya Artham, Carl J Lavie

  • 1Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, The University of Queensland School of Medicine, New Orleans, LA 70121-2483, USA.

Postgraduate Medicine
|May 14, 2011
PubMed
Summary

Erectile dysfunction (ED) is a significant risk factor for cardiovascular disease (CVD). Understanding their shared risk factors and pathophysiological links is crucial for managing both conditions effectively in millions of men worldwide.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Urology
  • Public Health

Background:

  • Cardiovascular disease (CVD) and erectile dysfunction (ED) are increasingly recognized as interconnected health issues.
  • ED affects approximately 140 million men globally, with numbers projected to double in 15 years.
  • Shared risk factors link ED and CVD, making their relationship a critical area of medical concern.

Purpose of the Study:

  • To examine the association and pathophysiological relationship between ED and CVD.
  • To review common risk factors, current treatments, and management strategies for both conditions.
  • To discuss the implications of sexual activity for patients with CVD.

Main Methods:

  • Literature review of studies investigating the link between ED and CVD.
  • Analysis of shared risk factors and underlying pathophysiological mechanisms.
  • Synthesis of current treatment and management approaches.

Main Results:

  • ED is established as a significant risk factor for CVD.
  • Numerous studies confirm the strong association between ED and CVD.
  • Shared risk factors underscore the pathophysiological connection.

Conclusions:

  • The link between ED and CVD is well-established, necessitating integrated management approaches.
  • Early identification of ED can serve as an indicator for underlying CVD.
  • Further research into shared mechanisms and treatment optimization is warranted.